AstraZeneca PLC Stock Price History Beta (5Y Monthly) 0.194636 52-Week Change 24.14% S&P500 52-Week Change 20.43% 52 Week High 153.1 USD 52 Week Low 104.5 USD 50-Day Moving Average 147.43 USD 200-Day Moving Average 132.36 USD AZNCF Share Statistics Avg. Volume (3 month) 4.8K USD Avg...
Stay up-to-date on Astrazeneca plc (AZNCF) Dividends, Current Yield, Historical Dividend Performance, and Payment Schedule.
Astra's share price increased 13 percent, and Zeneca's rose 7.5 percent. The new company, AstraZeneca PLC, would be the number three pharmaceuticals firm in the industry. The US$37 billion merger was completed on April 6, 1999, 80 days after its announcement, and the new company's stock...
Discover real-time AstraZeneca PLC American Depositary Shares (AZN) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.
AZN Stock Price 1D 5D 1M 6M YTD 1Y 5Y 10Y MAX Basic Advanced +6.18% AstraZeneca PLC price and volume Combination chart with 2 data series. Chart represents AstraZeneca PLC price and volume over 1Y period The chart has 2 X axes displaying Time, and Time. The chart has 2 Y axes displ...
or By creating an account using any of the options above, you agree to theTerms of Use&Privacy Policy AZNCFAstraZeneca Plc Stock Split History 2.5K followers $137.952.41 (+1.78%)3:11 PM 01/24/25 Pink Current Info |$USD |Market Close ...
AstraZeneca market capitalization over time Evolution of AstraZeneca plc market cap in the past 5 years Market capitalizations are calculated from the opening stock price at the beginning of each month. Market Cap History of AstraZeneca plc ...
AstraZeneca PLC[1] (LSE: AZN, OMX: AZN, NYSE: AZN), is a large Anglo-Swedish pharmaceutical company formed on 6 April 1999 by the merger of Swedish Astra AB and British Zeneca Group PLC. Zeneca was part of Imperial Chemical Industries prior to a demerger in 1993.[2][3] AstraZeneca...
AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
AstraZeneca PLC(NYSE: AZN)Q2 2022 earnings call datedJul. 29, 2022 Corporate Participants: Andy Barnett—Head of Investor Relations Pascal Soriot—Executive Director and Chief Executive Officer Aradhana Sarin—Executive Director and Chief Financial Officer ...